Shield Therapeutics plc (AIM:STX)

Shield Therapeutics Revenue

In the year 2025, Shield Therapeutics had annual revenue of $49.70M USD with 54.45% growth. Shield Therapeutics had revenue of $28.25M in the half year ending December 31, 2025, with 202.44% growth.

• Revenue: $49.70M
• Revenue Growth: +54.45%
• P/S Ratio: 2.66
• Revenue / Employee: $788.90K
• Employees: 63
• Market Cap: 98.29M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.70M	17.52M	54.45%
Dec 31, 2024	32.18M	19.10M	145.93%
Dec 31, 2023	13.09M	7.59M	137.95%
Dec 31, 2022	5.50M	3.44M	167.35%
Dec 31, 2021	2.06M	-12.12M	-85.50%